Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dole Specialty Ingredients is a specialized division of Dole Asia Holdings dedicated to upcycling fruit side-streams into high-value functional ingredients. The company utilizes advanced extraction and processing technologies to transform fruit by-products like peels, seeds, and stems into enzymes, extracts, and powders for the nutraceutical, cosmeceutical, and food and beverage sectors. Their portfolio is anchored by bromelain, a potent proteolytic enzyme extracted from pineapple, alongside a range of fruit-derived antioxidants and fibers. By focusing on circular economy principles, Dole Specialty Ingredients provides sustainable, traceable, and science-backed raw materials for global health and wellness brands. The company operates with a commitment to the Dole Promise, aiming for zero fruit loss while delivering innovative solutions for digestive health, skin care, and inflammation management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dole Specialty Ingredients.